InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Kaufmann Gunnar F., Directeur Scientifique. Officer active across 1 companies, notably Oncternal Therapeutics, Inc.. Cumulatively, 2 reports have been recorded. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
029,867 shares0
Common Stock
SEC:0001209191-22-001972·
029,867 shares0
Common Stock
SEC:0001209191-22-001972:0·
2 of 2 declarations
About Kaufmann Gunnar F.
Gunnar F. Kaufmann is the Chief Scientific Officer at Oncternal Therapeutics, Inc. In this role, he oversees the company's research and development activities. His scientific expertise is essential to guide research initiatives and ensure innovation.
